Tivic Health appoints Christina Valauri to board; Karen Drexler resigns effective Sep 30

Valion Bio, Inc.

Christina Valauri appointed director effective July 1, 2024; will chair Nominations & Corp Gov Committee.
Valauri brings 30+ years capital markets experience; served as advisor since April 2023.
Karen Drexler resigns as director effective Sep 30, 2024; will remain as strategic advisor.
2024 annual meeting set for Aug 9; record date June 17; shareholder proposals due June 27.

item 5.02 item 5.08 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Karen Drexler

director

VBIO · Valion Bio, Inc.

Effective: 2024-09-30
Filed: June 18, 2024, 7:59 PM ET

On June 17, 2024, Karen Drexler tendered her resignation from the Board and each of the Compensation Committee, Audit and Risk Committee and Nominations and Corporate Governance Committee thereof, in each case effective September 30, 2024.

Appointed

Christina Valauri

director

VBIO · Valion Bio, Inc.

Effective: 2024-07-01
Filed: June 18, 2024, 7:59 PM ET

On June 17, 2024, the board of directors (the “Board”) of Tivic Health Systems, Inc. (the “Company”) appointed Christina Valauri as a director of the Company, effective July 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Drexler resigned as director at Valion Bio, Inc..

Action: resigned
Role: director

Exact text from the filing

On June 17, 2024, Karen Drexler tendered her resignation from the Board and each of the Compensation Committee, Audit and Risk Committee and Nominations and Corporate Governance Committee thereof, in each case effective September 30, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christina Valauri was appointed as director at Valion Bio, Inc..

Action: appointed
Role: director

Exact text from the filing

On June 17, 2024, the board of directors (the “Board”) of Tivic Health Systems, Inc. (the “Company”) appointed Christina Valauri as a director of the Company, effective July 1, 2024

View on SEC.gov

Valion Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-074605

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.